Celecoxib enhances radiosensitivity in medulloblastoma-derived CD133-positive cells

Cerebellar stem cells act as medulloblastoma-initiating cells in a mouse model and a neural stem cell signature characterizes a subset of human medulloblastomas

(2010) R Sutter et al.   ONCOGENE

The COX-2/PGE2 pathway: key roles in the hallmarks of cancer and adaptation to the tumour microenvironment

(2009) A. Greenhough et al.   CARCINOGENESIS

Evaluation of radiotherapy effect in resveratrol-treated medulloblastoma cancer stem-like cells

(2009) Kai-Hsi Lu et al.   CHILDS NERVOUS SYSTEM

A Phase II Study of Celecoxib in Combination with Paclitaxel, Carboplatin, and Radiotherapy for Patients with Inoperable Stage IIIA/B Non-Small Cell Lung Cancer

(2009) R. Mutter et al.   CLINICAL CANCER RESEARCH

18F-FLT and18F-FDG PET to measure response to radiotherapy combined with celecoxib in two colorectal xenograft models

(2009) Annelies Debucquoy et al.   INTERNATIONAL JOURNAL OF RADIATION BIOLOGY

Phase II, Randomized, Placebo-Controlled Trial of Neoadjuvant Celecoxib in Men With Clinically Localized Prostate Cancer: Evaluation of Drug-Specific Biomarkers

(2009) Emmanuel S. Antonarakis et al.   JOURNAL OF CLINICAL ONCOLOGY

PI3K pathway regulates survival of cancer stem cells residing in the perivascular niche following radiation in medulloblastoma in vivo

(2008) D. Hambardzumyan et al.   GENES & DEVELOPMENT

Phase II study of temozolomide, thalidomide, and celecoxib for newly diagnosed glioblastoma in adults

(2008) Santosh Kesari et al.   NEURO-ONCOLOGY

Tumor-growth–promoting cyclooxygenase-2 prostaglandin E2 pathway provides medulloblastoma therapeutic targets

(2008) Ninib Baryawno et al.   NEURO-ONCOLOGY

Oct-4 Expression Maintained Cancer Stem-Like Properties in Lung Cancer-Derived CD133-Positive Cells

(2008) Yu-Chih Chen et al.   PLoS One

SOX2Silencing in Glioblastoma Tumor-Initiating Cells Causes Stop of Proliferation and Loss of Tumorigenicity

(2008) Rosaria Maria Rita Gangemi et al.   STEM CELLS